Tracking can take up significant amounts of a PV team's time, in some cases up to 50%.
Transforming Pharmacovigilance (PV) Compliance
In May 2019, Huron surveyed 34 pharmaceutical leaders to better understand their organizations' current approach to these critical operations.
- Organizations lack a single source of truth for compliance information.
- PV teams shoulder an excessive administrative burden, translating to process and cost inefficiencies.
- Maintaining multiple compliance tracking tools may result in discrepancies or penalties during audits and inspections.